What you should know:
1. Clinicians have seen evidence that the virus has caused heart inflammation, acute kidney disease, neurological malfunctions, blood clots, intestinal damage and liver problems.
2. This damage has complicated treatments, making recovery less certain.
3. Clinicians fear the virus is replicating how it enters the human body to enter other areas like the GI tract, which has 100 times more ACE2 receptors than other parts of the body and has a larger surface area.
4. Researchers believe the damage may be in part because the human immune system creates an excess of cytokines to battle the virus, which damages multiple organs.
When the body creates too many cytokines, “it can be a complete disaster,” said Jeffrey Weber, MD, PhD, deputy director of the Perlmutter Cancer Center at New York City-based NYU Langone Medical Center.
Read the entire report here.
More articles on healthcare:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.